Found: 4
Select item for more details and to access through your institution.
Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2209, doi. 10.1177/13524585211049391
- By:
- Publication type:
- Article
COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0255316
- By:
- Publication type:
- Article
Impact of vaccination on COVID‐19 outcome in multiple sclerosis.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 11, p. 3329, doi. 10.1111/ene.15488
- By:
- Publication type:
- Article
Long‐term outcome after COVID‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 10, p. 3050, doi. 10.1111/ene.15477
- By:
- Publication type:
- Article